Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
This article explains which coins beginners should consider for long term holding, emphasizing diversification and prudent risk.
28,247 articlesEli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
XRP’s price enters zone near a key support as spot XRP ETFs pour in capital. Traders weigh fear-driven selling agains...
The White House announced a temporary waiver of the Jones Act to boost crude shipments between U.S. ports. Early mark...
Chip stocks pause after a blistering run, with Intel crashing 10%, slides as investors take profits and reassess AI m...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...
A weekend military action in the Middle East pushed Treasuries higher and lifted mortgage rates, complicating spring ...
Wells Fargo cuts Gartner's price target to $140 as macro volatility tied to geopolitical tensions and AI competition ...
Savers are rethinking cash holdings as rates rise. Here are three higher-yield alternatives traditional savings that ...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Applied Optoelectronics led a broader retreat in photonics stocks on July 2, 2026, with Coherent and Lumentum sliding...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...
A new recession indicator signals Americans are financially tighter than forecasts suggested. This article breaks dow...